imipramine has been researched along with Bladder Cancer in 1 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Turner, RM | 1 |
Love, CC | 1 |
McDonnell, SM | 1 |
Sweeney, RW | 1 |
Twitchell, ED | 1 |
Habecker, PL | 1 |
Reilly, LK | 1 |
Pozor, MA | 1 |
Kenney, RM | 1 |
1 other study available for imipramine and Bladder Cancer
Article | Year |
---|---|
Use of imipramine hydrochloride for treatment of urospermia in a stallion with a dysfunctional bladder.
Topics: Abdominal Neoplasms; Adrenergic Uptake Inhibitors; Animals; Carcinoma, Transitional Cell; Female; Ho | 1995 |